The most frequently used keywords in the most cited papers and keywords identified in cooccurrence analysis in the most recent articles are semaglutide, obesity, diabetes mellitus type 2, glucagon-like peptide-1, glucagon-like peptide-1 receptor agonist, antidiabetic agent, liraglutide, and cardiovascular disease. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.